Multivariate analysis of predictors of death, MACCE and TVR
| Wald's χ2 | HR (95% CI) | p Value | |
|---|---|---|---|
| Death | |||
| Age (years) | 21.3 | 1.08 (1.05 to 1.12) | <0.001 |
| LVEF <40% | 31.4 | 3.28 (2.16 to 4.98) | <0.001 |
| Diabetes mellitus | 7.35 | 2.38 (1.27 to 4.48) | 0.007 |
| Prior CABG | 11.74 | 13.9 (3.09 to 63) | 0.001 |
| Chronic total occlusion | 9.1 | 2.93 (1.46 to 5.88) | 0.003 |
| MACCE | |||
| Age (years) | 12.6 | 1.03 (1.01 to 2.2) | <0.001 |
| LVEF <40% | 9.39 | 2.79 (1.45 to 5.39) | 0.002 |
| Multi-vessel disease | 5.99 | 1.66 (1.11 to 2.49) | 0.014 |
| Diastolic blood pressure | 5.59 | 1.02 (1.0 to 1.03) | 0.018 |
| Chronic total occlusion | 5.26 | 1.71 (1.08 to 2.71) | 0.022 |
| Target vessel=LM | 9.38 | 2.79 (1.45 to 5.39) | 0.002 |
| TVR | |||
| Prior PCI | 9.84 | 3.01 (1.51 to 5.98) | 0.002 |
| Number of treated vessel | 11.61 | 1.76 (1.27 to 2.45) | 0.001 |
| Total length of implanted stents (per 10-mm length) | 1.23 | 1.23 (1.03 to 1.62) | 0.001 |
| LM lesion | 5.78 | 3.06 (1.23 to 7.64) | 0.016 |
CABG, coronary artery bypass graft; LM, left main stem; LVEF, left ventricular ejection fraction; MACCE, major adverse cardiac and cerebrovascular events; PCI, percutaneous coronary intervention; TVR, target vessel revascularisation.